Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 883 | 1,176 | 932 | 1,589 | 312 |
| Cost of Goods | 250 | 240 | 340 | 1,250 | 0 |
| Gross Profit | 630 | 920 | 580 | 350 | 310 |
| Operating Expenses | 3,260 | 2,620 | 3,700 | 3,480 | 3,540 |
| Operating Income | -2,377 | -1,444 | -2,768 | -2,891 | -3,228 |
| Interest Expense | 20 | 30 | 20 | 30 | 0 |
| Other Income | -283 | -16 | -32 | 1 | -2 |
| Pre-tax Income | -2,680 | -1,490 | -2,820 | -2,920 | -3,230 |
| Net Income Continuous | -2,689 | -1,495 | -2,820 | -2,900 | -3,239 |
| Net Income | $-2,689 | $-1,495 | $-2,820 | $-2,900 | $-3,239 |
| EPS Basic Total Ops | -57.62 | -31.21 | -60.02 | -67.23 | -74.43 |
| EPS Basic Continuous Ops | -57.58 | -31.21 | -60.00 | -67.29 | -74.46 |
| EPS Diluted Total Ops | -57.62 | -31.21 | -60.02 | -67.23 | -74.43 |
| EPS Diluted Continuous Ops | -57.58 | -31.21 | -60.00 | -67.29 | -74.46 |
| EBITDA(a) | $-2,267 | $-1,404 | $-2,738 | $-2,941 | $-3,158 |